Medacta Group SA Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
CHF 148.60
9.20 (6.60%)
16.9% undervalued intrinsic discount
CHF 178.87
Fair Value
Price CHF 148.60
AnalystConsensusTarget CHF 178.87
Fair ValueCHF 178.87
Share Pricen/a
MOVE Community Narratives
AN

Fair Value CHF 178.87 16.9% undervalued intrinsic discount
Earnings Guidance And Updated Outlook Will Drive Expansion Across New Markets
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
Earnings Guidance And Updated Outlook Will Drive Expansion Across New Markets
Key Takeaways Geographic and strategic acquisitions promise revenue growth through enhanced market penetration and operational capabilities, especially in sports medicine. Innovative product rollouts and medical education investments are expected to drive revenue by capturing market share and increasing solution adoption.Read more
36
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN

CHF 178.87
16.9% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
12.73% p.a.
Profit Margin
13.49%
Future PE
36.01x
Price in 2029
CHF 205.93
Trending Discussion
Recently Updated Narratives
AN

MOVE: Higher Growth Assumptions And Richer P/E Will Support Gradual Upside
Fair Value: CHF 178.87 16.9% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Medacta Group SA Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Mar 13, 2026
- 4.76
- 67.61%
- 14.69%
- 48.0%
About MOVE
- Founded
- 1958
- Employees
- 2041
- CEO
- Website
View website
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.